MedTrace Logo

Trial Comparing Different Methods of Support With Stopping Smoking (PORTSSS/Stop Together Trial)

NCT00775944 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 2591

Last updated 2012-10-26

Study results available
· View outcomes & findings →

Summary

This study shall determine whether or not proactive telephone support for smoking cessation delivered to quitline callers is more effective than standard 'reactive' provision and whether or not the offer of a voucher for a cost free supply of nicotine replacement therapy (NRT) has any additional impact on smoking cessation rates achieved by behavioural interventions.

Conditions

  • Tobacco Smoking

Interventions

BEHAVIORAL

Proactive telephone support

Pro-active telephone counselling allows for repeated, sequenced calls to be made by quitline counsellors to smokers and for counselling to be provided during accepted calls.

BEHAVIORAL

Reactive (standard) telephone support

Reactive counselling usually involves the provision of evidence-based information to support quit attempts without any or with only very brief counselling to accompany it.

DRUG

Offer of voucher for cost-free Nicotine Replacement Therapy

Offer of voucher for cost-free Nicotine Replacement Therapy over the telephone

Sponsors & Collaborators

  • Department of Health, United Kingdom

    collaborator OTHER_GOV

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Tim Coleman, MB ChB · University of Nottingham

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2010-02-28
Completion
2010-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00775944 on ClinicalTrials.gov